DL-Norvaline | CAS:760-78-1

We serve DL-Norvaline CAS:760-78-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
DL-Norvaline
DL-Norvaline
CAS RN: 760-78-1
 

Solubility in 3M-HCl Colorless & clear (c=5)
Loss on drying Not more than 0.3%
Residue on ignition (as sulfate) Not more than 0.1%
Chloride (Cl) Not more than 0.03%
Sulfate (SO4) Not more than 0.03%
Heavy metals (as Pb) Not more than 10ppm
Iron (Fe) Not more than 10ppm
Ammonium (NH4) Not more than 0.02%
Arsenic (As2O3) Not more than 1ppm
Other amino acids Not detected by T.L.C.(The spotted amount, 20μg)
Assay 98.5%~101.0%

 



Contact us for information like DL-Norvaline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,rac-norvaline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DL-2-Aminopentanoic acid Use and application,rac-norvaline technical grade,usp/ep/jp grade.


Related News: The UK Foreign Office advised Britons against all but essential travel to mainland China, and airlines around the world suspended flights or offered full refunds or destination and date changes.2-Bromo-4'-nitroacetophenone manufacturer However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.Diethyl(3-pyridyl)borane supplier However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.